Radiation Oncology Department Receives National Accreditation
New Britain [November 05 2007] -
The Hospital of Central Connecticut’s Radiation Oncology Department is one of just five radiation oncology providers statewide to be accredited by the American College of Radiology (ACR).
Three-year accreditation was granted Oct. 23 after a comprehensive, daylong site visit by an ACR team of board-certified medical physicists and physicians specializing in radiation therapy. The team assesses staff members’ qualifications, adequacy of equipment and all other aspects of patient care to determine if they meet rigorous national standards.
“Accreditation by the ACR objectively verifies our commitment to quality care and patient safety,” says George Pavlonnis, MS, DABR, chief medical physicist of the hospital’s Radiation Oncology Department.
The Hospital of Central Connecticut performs most radiation therapy on an outpatient basis at its American Savings Foundation Radiation Oncology Treatment Center. Radiation oncology staff include radiation oncologists, medical physicists, medical dosimetrists, radiation therapists and oncology nurses that are all certified in their specialty.
Based on the level of quality inspectors found at the hospital, the Reston, Va.-based ACR has invited Pavlonnis to serve as a volunteer inspector for other facilities nationwide seeking ACR accreditation.
Pavlonnis, who serves on the board of directors of the Connecticut Area Medical Physics Society, is also working with the Connecticut Department of Environmental Protection to revise radiation therapy regulations. DEP officials have asked him to set up a training program at The Hospital of Central Connecticut for DEP inspectors who evaluate Connecticut radiation oncology facilities.
Radiation therapy is part of the hospital’s comprehensive line of cancer services, and includes a wide variety of advanced techniques and technologies to treat different cancers. The American Savings Foundation Radiation Oncology Treatment Center is being expanded to accommodate a new stereotactic radiosurgery system that, starting next fall, will be used to treat brain and other tumors without incisions.
Contact: Nancy Martin, 860-224-5900, ext. 4366
HCC Corporate Communications
(860) 224-5695 •
Fax (860) 224-5779